Presented by Prof Dr Mariana Brandão (Jules Bordet Institute) and Prof Dr Corinne Faivre-Finn (The Christie NHS Foundation Trust, Manchester, UK)
The optimal management of stage III NSCLC continues to be a subject of intense discussion. During the 2024 European Lung Cancer Conference (ELCC), a debate was organized in which Prof Dr Corinne Faivre-Finn (The Christie NHS Foundation Trust, Manchester, UK) and Dr Jonathan Spicer (McGill University Health Center, Motréal, Canada) respectively made a case for the use of radiotherapy or surgery in these patients. Before entering the debate arena, Prof Dr Faivre-Finn joined Dr Mariana Brandao (Institut Jules Bordet, Brussels, Belgium) to share her position on this topic.
For Prof Faivre-Finn the treatment decision in stage III NSCLC is not a black-or-white story between resection or surgery. In clinical practice, the situation is much more nuanced and requires a tailored approach in which the right treatment strategy is used for the right patient. In recent years, stage III NSCLC has been a field of intensive research. These research efforts resulted in the establishment of chemoradiotherapy followed by consolidation durvalumab as the standard of care for unresectable patients. In addition, a long list of clinical trials have demonstrated the potential benefit of adjuvant, neo-adjuvant, or perioperative immunotherapy-based therapy in resectable stage III patients.
To data, there is a lack of prospective data comparing these two treatment approaches in stage III NSCLC patients. This can make treatment choices challenging, especially in ‘borderline resectable’ patients. When opting for a certain treatment approach it is important to look beyond hard clinical endpoints such as progression-free or overall survival and also take quality of life and patient preference into consideration. As such, treatment choices for stage III NSCLC patients require a multidisciplinary discussion and should always take into account the opinion of the individual patient.
Donderdag 12 november 2026
Kontich
Gent
Linter
Onthaal vanaf 18 uur
Programma van 19 tot 22 uur
Kies jouw locatie en schrijf je in
Donderdag 12 november 2026
Kontich
Gent
Linter
Onthaal vanaf 18 uur
Programma van 19 tot 22 uur
Kies jouw locatie en schrijf je in